2018/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2018, Issue 3

Commentary

Medicines regulation in the MENA region and the importance of the World Health Organization’s INN proposal of Biological Qualifier

Original Research

Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at various temperatures

Implementing a treatment registry for a biosimilar: continuous safety surveillance of the biosimilar Bevax® (bevacizumab) in Argentina

In vitro analytical and antibiotic comparison of generic moxifloxacin against E. coli and S. aureus bacteria strains

Meeting Report

First ASEAN educational workshop on regulation and approval of biosimilars/similar biotherapeutic products 2017 – Report

Abstracted Scientific Content

EU risk-sharing agreements between 2000−2015

How does generic drug policy affect market prices?

Source URL: https://gabi-journal.net/2018-3-gabi-journal-table-of-contents.html